Literature DB >> 12962909

Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.

J D Yang1, G Y Feng, J Zhang, J Cheung, D St Clair, L He, Keiichi Ichimura.   

Abstract

Polymorphisms at positions -491, -427 and -219 in the promoter region of the Apolipoprotein E APOE gene have been variously reported to confer an increased risk of developing Alzheimer's disease (AD) independent of the effect of epsilon 2, 3 or 4 alleles in exon 4. In order to assess APOE promoter polymorphisms as independent risk factors in AD we have compared results in 183 definite or probable AD cases with 133 controls. We assayed markers at sites -491, -427, -219, and +113 in APOE gene and a polymorphic Hha1 site in the nearby APOC1 gene. We found that APOE promoter polymorphisms and APOC1 insertion alleles were significantly associated with AD. However, after stratification for epsilon 4 allele, only the A allele at -491 in APOE remained significantly associated with AD. The effects of the other markers depended almost entirely upon linkage disequilibrium with epsilon 4 allele, and only trends remained when cases and controls were stratified for the presence or absence of epsilon 4 allele. This occurred irrespective of whether markers were examined separately or together as haplotypes. So in the Chinese population only APOE -491 promoter alleles confer significant risk of AD independent of epsilon 4 status.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962909     DOI: 10.1016/s0304-3940(03)00815-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Analysis of SLCO1B1 and APOE genetic polymorphisms in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Bin Li; Cunren Li; Zhidong Liu; Min Yang; Qifeng Zhang; Wei Zhong; Pingsen Zhao
Journal:  J Clin Lab Anal       Date:  2018-02-09       Impact factor: 2.352

2.  Non-reporting and inconsistent reporting of race and ethnicity in articles that claim associations among genotype, outcome, and race or ethnicity.

Authors:  H Shanawani; L Dame; D A Schwartz; R Cook-Deegan
Journal:  J Med Ethics       Date:  2006-12       Impact factor: 2.903

3.  Association between Alzheimer disease and the -491T allele of regulatory region polymorphism of Apolipoprotein E in a Tunisian population.

Authors:  Afef Achouri-Rassas; Sondes Hadj Fredj; Hela Mrabet Khiari; Amina Bibi; Hajer Siala; Amel Mrabet; Taieb Messaoud
Journal:  Neurochem Res       Date:  2013-12-11       Impact factor: 3.996

4.  The complex interaction between APOE promoter and AD: an Italian case-control study.

Authors:  Alessandra Bizzarro; Davide Seripa; Adele Acciarri; Maria Giovanna Matera; Alberto Pilotto; Francesco Danilo Tiziano; Christina Brahe; Carlo Masullo
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

5.  Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.

Authors:  Hanyan Xiao; Yifeng Gao; Lei Liu; Yan Li
Journal:  EXCLI J       Date:  2017-06-20       Impact factor: 4.068

6.  Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Hesen Wu; Pingsen Zhao
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

7.  Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.

Authors:  Qian Chen; Ting Wang; Deying Kang; Lei Chen
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

8.  Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.

Authors:  Qin Zhou; Fan Zhao; Ze-ping Lv; Chen-guang Zheng; Wei-dong Zheng; Liang Sun; Na-na Wang; Shenghang Pang; Fabiana Michelsen de Andrade; Mian Fu; Xiang-hua He; Juan Hui; WenyYu Jiang; Chu-yu Yang; Xiao-hong Shi; Xiao-quan Zhu; Guo-fang Pang; Yi-ge Yang; Hai-qun Xie; Wan-dong Zhang; Cai-you Hu; Ze Yang
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.

Authors:  Anna Limon-Sztencel; Beata S Lipska-Ziętkiewicz; Magdalena Chmara; Bartosz Wasag; Leszek Bidzan; Beata R Godlewska; Janusz Limon
Journal:  Alzheimers Res Ther       Date:  2016-05-19       Impact factor: 6.982

10.  The SNPs rs429358 and rs7412 of APOE gene are association with cerebral infarction but not SNPs rs2306283 and rs4149056 of SLCO1B1 gene in southern Chinese Hakka population.

Authors:  Heming Wu; Qingyan Huang; Zhikang Yu; Hailing Wu; Zhixiong Zhong
Journal:  Lipids Health Dis       Date:  2020-09-05       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.